Jean-François Pujol
Chief Tech/Sci/R&D Officer at Biocortech SAS
Jean-François Pujol active positions
| Companies | Position | Start | End |
|---|---|---|---|
Biocortech SAS
 Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Career history of Jean-François Pujol
Former positions of Jean-François Pujol
| Companies | Position | Start | End |
|---|---|---|---|
| University of Lyon | Corporate Officer/Principal | - | - |
| Roussel Uclaf SA | Corporate Officer/Principal | - | - |
Training of Jean-François Pujol
| Ecole Centrale Lyon | Doctorate Degree |
Statistics
International
| France | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Health Technology |
| Roussel Uclaf SA | Health Technology |
- Stock Market
- Insiders
- Jean-François Pujol
- Experience
